Moreover, Abedini et al. (2014) demonstrated that low levels of GSN were found in chemo-sensitive patients, and overexpression of GSN is associated with an aggressive behavior of gynecological cancers [40]. This evidence concerns the gene GSN and female reproductive organ cancer.